Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.44B P/E - EPS this Y 22.00% Ern Qtrly Grth -
Income -364.93M Forward P/E -4.87 EPS next Y -22.70% 50D Avg Chg -3.00%
Sales 31.31M PEG -0.24 EPS past 5Y - 200D Avg Chg -2.00%
Dividend N/A Price/Book 1.39 EPS next 5Y 39.00% 52W High Chg -25.00%
Recommedations 2.20 Quick Ratio 9.16 Shares Outstanding 56.89M 52W Low Chg 23.00%
Insider Own 1.55% ROA -27.25% Shares Float 50.37M Beta 0.75
Inst Own 103.98% ROE -44.92% Shares Shorted/Prior 2.98M/3.46M Price 25.98
Gross Margin - Profit Margin - Avg. Volume 443,688 Target Price 56.20
Oper. Margin -1,228.29% Earnings Date Oct 31 Volume 377,945 Change -3.02%
About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Agios Pharmaceuticals, Inc. News
11/07/24 Agios Pharmaceuticals (NASDAQ:AGIO) Is Posting Healthy Earnings, But It Is Not All Good News
11/05/24 Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
11/01/24 AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down
11/01/24 Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?
11/01/24 Agios Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
11/01/24 Agios Pharmaceuticals Inc (AGIO) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
10/31/24 Agios Pharmaceuticals (AGIO) Misses Q3 Earnings and Revenue Estimates
10/31/24 Agios Pharmaceuticals: Q3 Earnings Snapshot
10/31/24 Agios Reports Business Highlights and Third Quarter 2024 Financial Results
06:00 AM Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease
10/17/24 Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024
09/27/24 Do Options Traders Know Something About Agios (AGIO) Stock We Don't?
09/26/24 Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
09/17/24 Agios Pharmaceuticals (AGIO) Appreciated after Positive Testing Results
09/14/24 Companies Like Agios Pharmaceuticals (NASDAQ:AGIO) Are In A Position To Invest In Growth
09/12/24 FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer
09/12/24 Agios Pharmaceuticals’ tebapivat gains FDA orphan drug designation
09/11/24 Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)
09/06/24 Why Is Zimmer (ZBH) Down 3.9% Since Last Earnings Report?
09/05/24 Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024
AGIO Chatroom

User Image Dkll303 Posted - 11 hours ago

$AGIO Let’s look into things ..how does CAT hold onto a high in the course of a day trading ??, and 379 dollars to hold the high How does PLTR do the same thing , even RYTM can hold its high , both only $60 and can do it !!! Then you come to this POS -AGIO and there is no investor group that is on board , WHY ? FOUSE !! That’s why !

User Image Dkll303 Posted - 11 hours ago

$AGIO Bear traps all day ..who would bother investing in a company that can’t bring serious investors on board. They can’t why ? Fouse and Goff are NOT CEO Material , never were !

User Image Tumble51 Posted - 12 hours ago

$AGIO And as stated , another dollar from 56.82 is collected !!! Shorts are the only buyers Goff can attract !!! What a hero he is to the short side of the market..THEY LOVE HIM He finds no buyers to screw them over !! Hahaha ..WEAK HANDS !

User Image Tumble51 Posted - 12 hours ago

$AGIO Goff shirks his fiduciary duty by allowing rampart shorting . But, he has no deep pockets associates and Schenkien BURNED HIS IN 2015 !!! So , another failed CEO !!! So these shareholders suffer with the misfits from biotech sector, clowns looked over before for CEO positions. Fouse at Celgene and Goff at Alexion Then there is the lab rat from Milellium Pharma , Schenkien ( who lied to the street in 2015 ) a nobody !

User Image Tumble51 Posted - 12 hours ago

$AGIO

User Image Tumble51 Posted - 12 hours ago

$AGIO the slogan at AGIOS !!! Clueless senior execs !!! $56 and FALLING

User Image Tumble51 Posted - 12 hours ago

$AGIO And the shorts now PUSH for the final hour …Goff is clueless to shareholders expectations . Let the shorts run wild he says , lol ..4.3M up from 2.9M !!

User Image Tumble51 Posted - 13 hours ago

$AGIO BUTT BOY , BERENS or is it Boat Boy of Jeffrey , shown his pathetic self yet ??? Either pumping gas into the boat or cleaning the decks , hahaha …

User Image Tumble51 Posted - 13 hours ago

$AGIO 8 by 8 …all done today …suckers buying their offering SHORT !

User Image Tumble51 Posted - 14 hours ago

$AGIO still at it …hoping a fool will think it is going higher and they take the bait of 800 offered , and then they slap the bid , haha

User Image BubblesMcGee123 Posted - 16 hours ago

$AGIO Is Editas, which is a gene-editing stock, targeting the same types of sickle cell anemia and thalassemia as Agios? I understand they have different treatment protocols, but are the two biotechs targeting the same patient pool? I'd like to know if they're in competition.

User Image Tumble51 Posted - 16 hours ago

$AGIO They ( shorts) love playing each other !! 8x8 , lol Like a sand box of Trump-Bullies

User Image Tumble51 Posted - 17 hours ago

$AGIO Shorts a bit aggressive today already …quick 10,000 shares

User Image Tumble51 Posted - 17 hours ago

$AGIO already begun today once again , lol …

User Image Tumble51 Posted - 19 hours ago

$AGIO BERENS at Leerink …did ya read what a hematologist MD had to say last night ??? Or were you pumping gas on Mass Ave and Columbus Ave ? Clearly , your abilities to disect blood disease are freshman year biology !!! But then you have missed ALNY as well, and clients are paying the price for your blunders

User Image Tumble51 Posted - 20 hours ago

$AGIO Good piece …although not a Felon Voter, nor support for a rapist, Melania was out in front with sickle cell in 2020, before their wonderful exit after millions were killed from Trump’s ignorance on COVID in China. Ya think Fouse was aware or an invitee to this, lol

User Image Tumble51 Posted - 20 hours ago

$AGIO $CPRX $IDYA $MYNZ time to post your crap on the right board , PINK SHEETS , lol @Jovanni_Day …

User Image TickerDD_com Posted - 20 hours ago

How much is $AGIO Shorted? What is Short Interest for AGIO? As of October 31 2024 Settlement Date https://youtu.be/7JrWLjj47ik

User Image mghmd Posted - 1 day ago

$AGIO Nice to see this in today's email from Am Soc of Hematology. This would be a plus for AGIO: ASH joined over 90 organizations in sending a letter to congressional leaders urging them to include the Sickle Cell Disease Comprehensive Care Act (H.R. 7432/S. 5097) in any year-end legislative package that may be considered by Congress. The Sickle Cell Disease Comprehensive Care Act would improve care for individuals with sickle cell disease through implementation of Medicaid Health Homes for sickle cell disease. Read the letter here, and visit the ASH Advocacy Center to send a message to your Representative and Senators urging their support for this important legislation.

User Image Wrangler4 Posted - 1 day ago

$AGIO At it again AH ..the shorts are constantly looking for an edge …Goff offers that with his lack of abilities to create value …Fouse couldn’t do it either….she brought a 10 year low to the company in 2022 !!! $16.95 ..just like her buddie did in 2015 , Schenkien , lol The 3 losers !

User Image Wrangler4 Posted - 1 day ago

$AGIO Again and time stamped , lol ….8 by 8 …😴😴😴😴😴🤣🤣🤣🤣

User Image Wrangler4 Posted - 1 day ago

$AGIO Oh the web they weave…..8 by 8 all day long ….shorts playing both sides !

User Image Wrangler4 Posted - 1 day ago

$AGIO 8 by 8 ..taking it DOWN …GUESS WHO !!!haha

User Image Wrangler4 Posted - 1 day ago

$AGIO Still that way …they never let it get away from them and Goldman aids the process !!! They too, are short !

User Image Wrangler4 Posted - 1 day ago

$AGIO Yes the constant Bid of 800 and the Ask of 800 is a big give away !! lol

User Image Tumble51 Posted - 1 day ago

$AGIO Lol..SSDD ….shorts taking control ..easily done, they Got Goff as their weapon !! Another middle mgnr , believing he can be a CEO

User Image Tumble51 Posted - 1 day ago

$AGIO Anyone seen BERENS from Leerink ??? Heard when it hit $60 11/11..clients called for his resignation !!!

User Image Tumble51 Posted - 1 day ago

$AGIO Bid and Ask is a short…no buyers !! lol …1700 days of No real buyers

User Image Tumble51 Posted - 1 day ago

$AGIO Already the shorts are at it , lol before 7 ! Wondering if Goff works this hard to create value , haha

User Image Dkll303 Posted - 2 days ago

$AGIO Ya…57.60 …why ? Lol …

Analyst Ratings
Leerink Partners Market Perform Sep 27, 24
Cantor Fitzgerald Overweight Sep 20, 24
RBC Capital Outperform Sep 19, 24
RBC Capital Outperform Aug 2, 24
Cantor Fitzgerald Overweight Jun 17, 24
Goldman Sachs Neutral Jun 4, 24
RBC Capital Outperform Jun 4, 24
Goldman Sachs Neutral May 3, 24
Cantor Fitzgerald Overweight Apr 9, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Schenkein David P Director Director Mar 27 Sell 22.15 20,000 443,000 117,879 03/29/23
Schenkein David P Director Director Mar 27 Option 9.05 20,000 181,000 137,879 03/29/23
Schenkein David P Director Director Mar 13 Sell 22.6 20,000 452,000 117,879 03/15/23
Schenkein David P Director Director Mar 13 Option 9.05 20,000 181,000 137,879 03/15/23
Washburn Theodore James Jr. Principal Accounting.. Principal Accounting Officer Feb 25 Sell 30 108 3,240 2,549 03/01/22
Washburn Theodore James Jr. Principal Accounting.. Principal Accounting Officer Feb 14 Option 0 360 3,413 02/16/22
Washburn Theodore James Jr. Principal Accounting.. Principal Accounting Officer Feb 14 Sell 31.25 504 15,750 2,782 02/16/22
Bowden Christopher Chief Medical Office.. Chief Medical Officer Jun 21 Option 39.76 2,502 99,480 17,989 06/21/21
Bowden Christopher Chief Medical Office.. Chief Medical Officer Jun 21 Sell 60.02 2,502 150,170 15,487 06/21/21
Bowden Christopher Chief Medical Office.. Chief Medical Officer Apr 21 Option 36.69 17,611 646,148 29,888 04/21/21